Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 36 pseudogene 1 (ANKRD36P1) is a human pseudogene located on the Y chromosome (Y:28,555,962-28,566,682, forward strand)[5]. It is classified as a pseudogene because it is a non-functional segment of DNA that resembles the functional gene ANKRD36, but it does not code for any functional protein product[3][5]. There are no recognized biological functions, disease associations, or therapeutic relevance for ANKRD36P1 at this time. Pseudogenes in general may, in some cases, have regulatory roles (such as acting as microRNA decoys), but there is no evidence for such a function for ANKRD36P1 specifically[7]. Key points: - ANKRD36P1 is not a therapeutic target, receptor, enzyme, or otherwise actionable biomolecule. - There are no known disease associations or interactions with drugs. - No biomarker, safety, or clinical considerations apply. - It is recognized solely as a non-coding pseudogene[3][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 36 pseudogene 1 (ANKRD36P1).